CEO " The FDA Has Signaled Openness & Willingness For Accelerated Approval". read link
Doing DD. Nice Read Here:
Seeking Alpha 1/10/13
But most importantly we are achieving alignment with all the stakeholders in the DMD community, so we’ve been working with patient advocates with investigators who are experts in Duchenne, and we believe the FDA has really signaled in several ways their openness and willingness to consider accelerated approval and for other expedited paths to approval for these types of devastating illnesses and including in the rare disease space.